BioRestorative Therapies, Inc. (BRTX) vs Moolec Science S.A. (MLEC)

A side-by-side comparison of BioRestorative Therapies, Inc. and Moolec Science S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BRTX vs MLEC

growth of $100 · dividends reinvested · last 6y
BRTX -99.8% (-64.5%/yr)MLEC -99.7% (-61.4%/yr)MLEC compounded faster over this window
050100150200Start $10020222023202420252026$0$0
BRTX MLEC

BRTX vs MLEC: by the numbers

  • •MLEC is the larger company ($3M vs $3M market cap).
  • •Both run net losses; MLEC's is the smaller (-105.71% vs -3089.55% net margin).

Metrics side by side

Valuation

MetricBRTXMLEC
P/S ratio8.57N/A
P/B ratio1.01N/A

Profitability

MetricBRTXMLEC
Gross margin92.09%34.17%
Operating margin-4350.05%-3.14%
Net margin-3089.55%-105.71%
ROE-365.43%-89.85%
ROIC-464.86%-33.50%

Growth (annualized)

MetricBRTXMLEC
Revenue CAGR (5Y)38.99%N/A
Total return CAGR (5Y)-61.44%-68.13%

Frequently asked

How have BRTX and MLEC total returns compared?
Over the past 5 years, BRTX delivered -61.44% and MLEC delivered -68.13% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.